CD8A and neoplasm: Together with an enhanced upregulation of major histocompatibility complex class I on tumor cells, this is leading to the expansion of non-self tumor neoantigen-specific T cell receptor (TCR) clones and enhanced CD8+ T cell-mediated tumor cell killing.